ResearcherJohns Hopkins UniversityNo recent work listed
Barry D. Nelkin
Matched on ORCID iD 0000-0002-1552-6377; OpenAlex author ID A5010169788; NIH RePORTER profile ID 1898931. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 1)
- Trials
- 0
- Grants
- 1
- Labs led
- 1
- Collaborators
- 25
2011: 1 paper · 2012: 1 grant · 2013: none · 2014: none · 2015: none · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: 1 paper
Papers 3
- A Phase I Study of Dinaciclib in Combination With MK-2206 in Patients With Advanced Pancreatic Cancer. Co-author DOI 10.1111/cts.12802↗
- Long-Term ERK Inhibition in KRAS-Mutant Pancreatic Cancer Is Associated with MYC Degradation and Senescence-like Growth Suppression. Co-author DOI 10.1016/j.ccell.2015.11.011↗
- Cyclin-dependent kinase inhibitor Dinaciclib (SCH727965) inhibits pancreatic cancer growth and progression in murine xenograft models. Last author DOI 10.4161/cbt.12.7.16475↗
Grants 1
Closest collaborators
The 25 strongest of 25 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Anirban Maitra · 3 shared papers, 1 shared grant, 2011–2020 · strength 0.29
- Grant Targeting CDK5 in Pancreatic Cancer: Mechanistic and Preclinical Development R01CA134767↗
- Paper A Phase I Study of Dinaciclib in Combination With MK-2206 in Patients With Advanced Pancreatic Cancer. DOI 10.1111/cts.12802↗
- Paper Long-Term ERK Inhibition in KRAS-Mutant Pancreatic Cancer Is Associated with MYC Degradation and Senescence-like Growth… DOI 10.1016/j.ccell.2015.11.011↗
- Aaron Richard Hansen · 1 shared paper, 2020 · strength 0.09
- Noelle K. LoConte · 1 shared paper, 2020 · strength 0.09
- Adrian Gerard Murphy · 1 shared paper, 2020 · strength 0.09
- Nilofer Saba Azad · 1 shared paper, 2020 · strength 0.09
- Lillian Siu · 1 shared paper, 2020 · strength 0.09
- Colin D. Weekes · 1 shared paper, 2020 · strength 0.09
- Nicole F. Neel · 1 shared paper, 2016 · strength 0.04
- Emanuel F. Petricoin · 1 shared paper, 2016 · strength 0.04
- Mariaelena Pierobon · 1 shared paper, 2016 · strength 0.04
- Kirsten L. Bryant · 1 shared paper, 2016 · strength 0.04
- Adrienne D. Cox · 1 shared paper, 2016 · strength 0.04
- Jen Jen Yeh · 1 shared paper, 2016 · strength 0.04
- Channing J. Der · 1 shared paper, 2016 · strength 0.04
- Tikvah K. Hayes · 1 shared paper, 2016 · strength 0.04
- Andrea Wang‐Gillam · 1 shared paper, 2016 · strength 0.04
- N.V. Rajeshkumar · 1 shared paper, 2011 · strength 0.02
- Georg Feldmann · 1 shared paper, 2011 · strength 0.02
- Volker Fendrich · 1 shared paper, 2011 · strength 0.02
- Niki A. Ottenhof · 1 shared paper, 2011 · strength 0.02
- Zeshaan A. Rasheed · 1 shared paper, 2011 · strength 0.02
- Manuel M. Hidalgo · 1 shared paper, 2011 · strength 0.02
- Savita Bisht · 1 shared paper, 2011 · strength 0.02
- William H. Matsui · 1 shared paper, 2011 · strength 0.02
- Ignacio Garrido‐Laguna · 1 shared paper, 2011 · strength 0.02
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.